Newsbot

Deutsche Anleihen: Kursverluste

FRANKFURT (dpa-AFX) - Die Kurse deutscher Staatsanleihen sind am Montag merklich gefallen. Der richtungweisende Euro-Bund-Future sank um 0,45 Prozent auf 128,31 Punkte. Die Rendite der zehnjährigen Bundesanleihe stieg auf 2,75 Prozent. Auch in den a...

Does Trump Want a Regime Change in Venezuela?

President Donald Trump has been putting the pressure on Venezuela and its leader Nicolas Maduro. Trump jolted the region Saturday, telling airlines to treat Venezuelan airspace as closed. Robert Koenigsberger of Gramercy Funds Management, talks about how this impacts investing in Venezuela and Latin America and if Trump is pushing for a regime change. (Source: Bloomberg)

Bloomberg Surveillance 12/1/2025

Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern speak daily with leaders and decision makers from Wall Street to Washington and beyond. No other program better positions investors and executives for the trading day. (Source: Bloomberg)

PROPOSED PLACING OF SHARES IN AMBEA AB (PUBL)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY, NOR SHALL THERE BE ANY SALE OF THE SECURITIES REFERRED TO HEREIN, IN OR INTO ANY JURISDICTION WHERE SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION O...

VNRX: 3Q 2025 results reported; Revenues & EPS above our expectations; cost cutting very evident. At least seven major operational milestones have been achieved thus far in 2025.

By Steven Ralston, CFANYSE:VNRXREAD THE FULL VNRX RESEARCH REPORTEXECUTIVE SUMMARYVolitionRx’s (NYSE:VNRX): Management’s primary operational goal for 2025 is to secure multiple licensing agreements for human diagnostic applications. In September 2025, Volition began significant progress toward the goal by signing two licensing agreements: a Nu.Q NETs Research License with Werfen S.A. for Antiphospholipid Syndrome (APS) and a co-marketing agreement with Hologic Diagenode for Nu.Q Discover se...

Kojamo plc: Share repurchase 1.12.2025

Kojamo plc, Stockexchange release, 1December 2025 at 06:30p.m. EETKojamo plc: Sharerepurchase 1.12.2025In the Helsinki StockExchangeTrade date           1.12.2025Bourse trade         BuyShare                  KOJAMOAmount             74,000 SharesAverage price/ share    10.4492 EURTotal cost            773,240.80 EURKojamo plc now holds atotal of 4,300,000sharesincluding the sharesrepurchased on1.12.2025The share buybacks areexecuted in com...

JPMorgan hebt Ziel für Prosus auf 79 Euro - Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Prosus von 74 auf 79 Euro angehoben und die Einstufung auf "Overweight" belassen. Marcus Diebel aktualisierte in einer am Montag vorliegenden Studie sein Bewertungsmodell für die Internet-Beteiligungsgesellschaft. Für 2026 senkte er zwar etwas seine Schätzungen wegen der Trends bei der Beteiligung Just Eat Takeaway und verstärkter KI-Invesitionen. [mehr]

Britische Pharma-Exporte in die USA künftig zollfrei

LONDON (dpa-AFX) - Anders als die Länder der Europäischen Union um Deutschland haben Großbritannien und Nordirland einen Null-Prozent-Zollsatz für Pharmaexperte in die USA ausgehandelt. Das berichtete am Abend die Nachrichtenagentur PA mit Verweis au...